-

ABR CLASS ACTION NOTICE: Glancy Prongay Wolke & Rotter LLP Files Securities Fraud Lawsuit On Behalf Of Arbor Realty Trust, Inc. (ABR) Investors

Lawsuit asserts claims on behalf of investors who acquired Arbor Realty Trust, Inc. securities between February 27, 2026 and October 30, 2026; lead plaintiff motions are due within 60 days of this notice.

LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay Wolke & Rotter LLP ("Glancy") announces that it has filed a class action lawsuit in the United States District Court Eastern District of New York, captioned Greenbaum v. Arbor Realty Trust Inc. et al., Case No. 1:26-cv-07231, on behalf of persons and entities that purchased or otherwise acquired Arbor Realty Trust, Inc. ("Arbor Realty" or the "Company") (NYSE: ABR) securities between February 27, 2026 and October 30, 2026, inclusive (the "Class Period"). Plaintiff pursues claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 (the "Exchange Act").

Investors are hereby notified that they have 60 days from the date of this notice to move the Court to serve as lead plaintiff in this action.

If you suffered a loss on your Arbor Realty Trust, Inc. investments, inquire about the Arbor Realty Trust, Inc. class action to learn about potentially pursuing claims to recover your loss under the federal securities laws.

Key details of the Arbor Realty Trust, Inc. case

  • Court: United States District Court Eastern District of New York
  • Case No.: 1:26-cv-07231
  • Class period: February 27, 2026 to October 30, 2026, inclusive
  • Claims: Sections 10(b) and 20(a) of the Exchange Act
  • Lead plaintiff motions: due within 60 days from the date of this notice

What happened?

On May 8, 2026, before the market opened, Arbor Realty issued a press release announcing first quarter 2026 results, including net income for the quarter of $0.6 million, compared to net income of $30.4 million for the same quarter in the prior year. The Company had 19 non-performing loans with an unpaid principal balance of $481.5 million, before related loan loss reserves of $16.1 million, compared to 26 non-performing loans with a UPB of $569.1 million, before related loan loss reserves of $10.2 million as of December 31, 2025. During the related conference call held the same day, the Company’s Chief Executive Officer, Ivan Kaufman, stated the Company was “pushing our timetable out a little bit” to resolving nonperforming and subperforming loans. Further, the Company’s Chief Financial Officer, Paul Elenio, purported to reassure investors that the Company maintained its “expectation that we will resolve the bulk of our delinquent loans by the end of the year.” Elenio stated, “This should put our REO assets between $250 million and $300 million by the end of ‘26 and greatly improve our run rate of income for the future.”

On this news, Arbor Realty stock fell $0.96, or 11.75%, to close at $7.21 on May 8, 2026, thereby injuring investors.

Then, on October 30, 2026, before the market opened, Arbor Realty issued a press release announcing its financial results for the third quarter of 2026. Among other things, the Company reported a GAAP net loss of $(85.4) million and that the Company would suspend its quarterly cash dividend. The Company revealed the number of nonperforming loans had increased from 19 to 32 and they had a UPB of $647.6 million, before related loan loss reserves of $41.9 million. During the related earnings call, Defendant Kaufman disclosed the Company “ended the third quarter with approximately $750 million of delinquencies and around $500 million of REO assets for total nonperforming assets of roughly $1.25 billion, which is up around $200 million from last quarter’s numbers.”

On this news, Arbor Realty stock fell $0.88, or 29.14%, to close at $2.14 on October 30, 2026, thereby further injuring investors.

What is the Arbor Realty Trust, Inc. lawsuit about?

The complaint filed in this class action alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company's business, operations, and prospects. Specifically, Defendants failed to disclose to investors that: (1) the loans Defendants described as “ring-fenced” were not contained; (2) the Company lacked a reasonable basis to represent that the Company would resolve nearly all existing delinquencies by year-end 2026; (3) the Company could not reasonably reduce its REO balance at the pace predicted by year-end 2026; (4) the resulting losses, reserves, and impairments threatened the Company’s earnings and its ability to sustain its dividend; and (5) as a result, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis at all relevant times.

If you purchased or otherwise acquired Arbor Realty Trust, Inc. securities during the Class Period, you may move the Court no later than 60 days from the date of this notice to ask the Court to appoint you as lead plaintiff.

Contact us to participate or learn more

If you wish to learn more about this action, or if you have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Glancy about the Arbor Realty Trust, Inc. lawsuit, email shareholders@glancylaw.com, or call 310-201-9150 (toll-free: 888-773-9224).

If you inquire by email, please include your mailing address, telephone number, and number of shares purchased.

To be a member of the Class you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the Class. No class has been certified yet in the Arbor Realty Trust, Inc. case.

Frequently Asked Questions

Who is eligible? Persons and entities that purchased or otherwise acquired Arbor Realty Trust, Inc. securities between February 27, 2026 and October 30, 2026 and suffered losses may be members of the proposed class in the Arbor Realty Trust, Inc. securities lawsuit.

What is the Arbor Realty Trust, Inc. lead plaintiff deadline? Motions to serve as lead plaintiff in the Arbor Realty Trust, Inc. class action must be filed within 60 days from the date of this notice.

What is a lead plaintiff? In the Arbor Realty Trust, Inc. class action, the lead plaintiff is the investor, or group of investors, that the court appoints to represent all class members and oversee the case. Under the Private Securities Litigation Reform Act, courts generally presume the movant with the largest financial interest is the most adequate lead plaintiff.

Does it cost anything to contact Glancy or participate in this action? Glancy represents Arbor Realty Trust, Inc. investors on a contingency fee basis, so investors pay no attorneys' fees out of pocket. Any attorneys' fees and litigation expenses are paid only from a recovery, if one is obtained, and are subject to court approval.

Why work with Glancy on the Arbor Realty Trust, Inc. lawsuit? Glancy Prongay Wolke & Rotter LLP is a premier law firm with decades of experience representing investors and consumers in securities litigation and other complex class action litigation. Contact Glancy about the Arbor Realty Trust, Inc. class action. Prior results do not guarantee a similar outcome.

About Glancy Prongay Wolke & Rotter LLP

Glancy was named one of Law360's Securities Groups of the Year and ranked second in total investor recoveries by ISS Securities Class Action Services in 2025.

Glancy's successes have been widely covered by leading news and industry publications, including The Wall Street Journal, The Financial Times, Bloomberg Businessweek, Reuters, the Associated Press, Barron's, Investor's Business Daily, Forbes, and Money.

Prior results do not guarantee a similar outcome.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contacts

Charles H. Linehan
Glancy Prongay Wolke & Rotter LLP
1925 Century Park East, Suite 2100
Los Angeles, CA 90067
Email: shareholders@glancylaw.com
Telephone: 310-201-9150 | Toll-free: 888-773-9224
www.glancylaw.com
Follow Glancy on LinkedIn, X, or Facebook.

Glancy Prongay Wolke & Rotter LLP

NYSE:ABR

Release Versions

Contacts

Charles H. Linehan
Glancy Prongay Wolke & Rotter LLP
1925 Century Park East, Suite 2100
Los Angeles, CA 90067
Email: shareholders@glancylaw.com
Telephone: 310-201-9150 | Toll-free: 888-773-9224
www.glancylaw.com
Follow Glancy on LinkedIn, X, or Facebook.

More News From Glancy Prongay Wolke & Rotter LLP

Deadline Alert: O-I Glass, Inc. Investors Have Until December 28, 2026 to Seek Lead Plaintiff Role in Securities Fraud Class Action, Glancy Prongay Wolke & Rotter LLP Reminds Investors

LOS ANGELES--(BUSINESS WIRE)--Investors in O-I Glass, Inc. ("O-I Glass" or the "Company") (NYSE: OI) have until December 28, 2026 to ask the Court to appoint them lead plaintiff in a securities fraud class action lawsuit filed on behalf of investors who purchased or otherwise acquired O-I Glass, Inc. securities between March 14, 2025 and July 28, 2026, inclusive. Glancy Prongay Wolke & Rotter LLP ("Glancy") today reminded investors of the upcoming deadline. The O-I Glass, Inc. case, Bryan v....

Securities Fraud Class Action Filed Against Lululemon Athletica, Inc: Glancy Prongay Wolke & Rotter LLP Announces Lead Plaintiff Deadline

LOS ANGELES--(BUSINESS WIRE)--A securities fraud class action lawsuit has been filed against Lululemon Athletica, Inc ("Lululemon" or the "Company") (NASDAQ: LULU) on behalf of investors who purchased or otherwise acquired the Company's securities between March 18, 2026 and September 3, 2026, inclusive. Glancy Prongay Wolke & Rotter LLP ("Glancy") today announced the filing. The Lululemon Athletica, Inc case, Koronczi v. lululemon athletica inc. et al., was filed on November 2, 2026 in the U...

Lost Money on Madrigal Pharmaceuticals, Inc. Stock? Glancy Prongay Wolke & Rotter LLP Investigates Possible Securities Fraud After 8.1% Share Price Drop

LOS ANGELES--(BUSINESS WIRE)--Investors who lost money on Madrigal Pharmaceuticals, Inc. ("Madrigal" or the "Company") stock may have claims to recover their losses. Glancy Prongay Wolke & Rotter LLP ("Glancy") today announced a securities fraud investigation on behalf of Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) investors into whether the Company may have violated the federal securities laws. The investigation follows the November 3, 2026 disclosure regarding Madrigal Pharmaceuticals,...
Back to Newsroom